v3.24.4
Stockholders’ Deficit (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 03, 2024
Apr. 17, 2024
Mar. 15, 2024
Jan. 24, 2024
Dec. 18, 2023
Sep. 29, 2023
Apr. 01, 2023
Jan. 01, 2023
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Jun. 14, 2024
Dec. 31, 2023
Nov. 11, 2021
Jan. 09, 2020
Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Common stock, shares authorized                 125,000,000           125,000,000 125,000,000 125,000,000 45,000,000 25,000,000 5,000,000
Preferred stock, shares authorized                 5,000,000           5,000,000   5,000,000      
Common stock, shares issued                 30,126,413           30,126,413   26,526,405      
Common stock, shares outstanding                 30,126,413           30,126,413   26,526,405      
Preferred stock, shares issued                                  
Preferred stock, shares outstanding                                  
Share price     $ 1.33                                  
Aggregate sale of common stock, value                   $ 75,000                    
Restricted stock fair value                                      
Compensation expense for services                             $ 504,077          
Stock based compensation                 $ 195,056 $ 276,983 $ 355,317 $ 253,013 $ 350,862 $ 381,501 827,356          
Unvested stock options expense                             $ 466,416          
Granted stock option purchase shares                             297,105          
Stock option exercise price                             $ 1.33          
Grant date fair value                 3,316,141           $ 3,316,141   $ 3,316,119      
Restricted Stock Units (RSUs) [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of restricted shares issued, shares     7,500   1,618,537 1,399,834                 1,626,037          
Share price     $ 1.33   $ 1.33 $ 1.33                            
Restricted stock fair value         $ 2,158,050 $ 1,866,445                 $ 2,195,550          
Compensation expense for services     $ 40,000                                  
Number of restricted shares terminated         1,399,384                              
Chief Financial Officer [Member] | Share-Based Payment Arrangement, Option [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Granted stock option purchase shares               562,500                        
Stock option exercise price               $ 1.33                        
Grant date fair value               $ 589,500                        
Employee and Consultants [Member] | Share-Based Payment Arrangement, Option [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Granted stock option purchase shares             562,500                          
Stock option exercise price             $ 1.33                          
Grant date fair value             $ 577,500                          
Consultant [Member] | Share-Based Payment Arrangement, Option [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Granted stock option purchase shares   67,500   180,000                                
Stock option exercise price   $ 1.33   $ 1.33                                
Grant date fair value   $ 73,459   $ 190,560                                
IPO [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Gross proceeds $ 10,000,000                                      
Restricted stock fair value $ 4,638,375                                      
Common Stock [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of restricted shares issued, shares                   3,487,500                    
Sale of common stock, net of receivables, shares                   112,500                    
Aggregate sale of common stock, value                             $ 75,000          
Restricted stock fair value                   $ 349                    
Stock based compensation                            
Common Stock [Member] | IPO [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of restricted shares issued, shares 3,487,500                                      
Sale of common stock, net of receivables, shares 37,500                                      
Share price $ 1.33                                      
Aggregate sale of common stock, shares                             37,500          
Common Stock [Member] | IPO [Member] | Entity One [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of restricted shares issued, shares 1,162,500                                      
Common Stock [Member] | IPO [Member] | Entity Two [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of restricted shares issued, shares 1,162,500                                      
Common Stock [Member] | IPO [Member] | Entity Three [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of restricted shares issued, shares 1,162,500